QIAGEN Clinical Insights platform growing at over 35% annually, or 700,000 additional cases, and recently breaking through three million cases analyzed and reported Total number of analyzed and reported patient cases using QCI five times higher than other commercial offerings Unique Augmented Molecular Intelligence approach provides customers with the ability to scale NGS testing with […]
The Life Science business of Merck adds 2.25 megawatts to the grid with 7,000 solar panels at its Sheboygan, Wisconsin, USA site, which are now fully installed. 7,000 solar panels produce energy to power 700 homes Part of We Energies’ “Solar Now” program, bringing more renewable energy to Wisconsin Reinforces company’s long-term commitment to renewable […]
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services Cambridge, UK: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services. The Company’s laboratory space has been […]
Merck today broke ground at its Sheboygan, Wisconsin site, for the company’s first lateral flow membrane production facility in the United States. New facility to manufacture the company’s Hi-Flow™ Plus lateral flow membrane used in rapid diagnostic test kit manufacturing, including Covid-19 Facility supported by € 121 million U.S. Government contract award Supports strategy to […]
Global conference to focus on advancing the transformative impacts of genomic health SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that former President of the United States Barack Obama will participate in a moderated Q&A conversation at the inaugural Illumina Genomics Forum, the company’s global event focused […]
A screening tool developed in research led at the University of Strathclyde, UK could increase the number of tests on a solid tumour sample by up to 50 times. The tool is designed for testing at scale the latest immunotherapies, such as Chimeric Antigen Receptor (CAR) T-cell therapy, which is effective against many haematological cancers but presents challenges when used to treat solid […]
Construction completed for expanded facility within California headquarters SANTA ANA, California, July 14, 2022: FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, has announced the completion of its Armstrong Cell Culture Center of Excellence. More than doubling the R&D […]
The Science Based Targets initiative has validated Illumina’s targets to reach Net-Zero greenhouse gas emissions by 2050 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first group of companies worldwide to receive approval of its net-zero targets by the Science Based Targets initiative (SBTi). […]
Application period for the Merck Uptune program starts today Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologies and materials in semiconductor and smart manufacturing Selected startups can receive funding of up to € 100,000 SHANGHAI — Merck, a leading science and technology company, today announced the launch of its […]
New site will strengthen Cytiva’s security of supply Cytiva, a global life sciences leader, is investing in additional resins manufacturing operations outside of Sweden, for the first time in the company’s history, with the acquisition of a new facility in Muskegon, Michigan. The new chromatography resins manufacturing site is part of Cytiva and Pall Corporation’s […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
